Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274554
Filing Date
2025-11-10
Accepted
2025-11-10 17:12:54
Documents
97
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agen-20250930.htm   iXBRL 10-Q 3236229
2 EX-10.1 agen-ex10_1.htm EX-10.1 132617
3 EX-10.2 agen-ex10_2.htm EX-10.2 65839
4 EX-10.3 agen-ex10_3.htm EX-10.3 100043
5 EX-31.1 agen-ex31_1.htm EX-31.1 17116
6 EX-31.2 agen-ex31_2.htm EX-31.2 17205
7 EX-32.1 agen-ex32_1.htm EX-32.1 11948
  Complete submission text file 0001193125-25-274554.txt   13210300

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20250930.xsd EX-101.SCH 1638759
100 EXTRACTED XBRL INSTANCE DOCUMENT agen-20250930_htm.xml XML 2542519
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 251467363
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)